Clinical Trial

A Study Testing the Safety and Effects of FB102 in Healthy Volunteers

Name: A Study Testing the Safety and Effects of FB102 in Healthy Volunteers — clinical trial record (NCT07623057)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this Phase 1 trial is to evaluate the safety and effects of FB-102 in healthy volunteers following single and multiple doses.

Trial Details

NCT Number	NCT07623057
Lead Sponsor	Forte Biosciences, Inc.
Conditions	Healthy Volunteer
Enrollment	56 participants
Start Date	2026-06
Primary Completion	2027-02 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2026-06-03